AmSurg receives ‘hold’ rating — 4 observations

Zacks analysts gave AmSurg a ranking of 3, indicting the company has a “hold” rating for the short term, according to Insider Trading Report.

Advertisement

Here are four observations:

1. In the short term, AmSurg shares are projected to reach $85.89.

2. Analysts predict the shares may hit a target price of $95 on the higher end and $64 on the lower end.

3. AmSurg shares are up nearly 17.8 percent in the last three-month period.

4. In the last four weeks, the shares rallied 0.53 percent.

More articles on surgery centers:
SCA receives ‘sell’ rating — 4 quick facts
Children’s Hospital of Philadelphia opens Brandywine Valley Specialty Care and ASC: 5 things to know
10 new surgery centers in September 2015

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.